Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens.
about
Dihydrostreptomycin or streptomycin in combination with penicillin G in dairy cattle therapeutics: a review and re-analysis of published data. Part 2: resistance and residues.Aminoglycoside modifying enzymes.KPC-producing Klebsiella pneumoniae strains that harbor AAC(6')-Ib exhibit intermediate resistance to amikacin.Reverse engineering antibiotic sensitivity in a multidrug-resistant Pseudomonas aeruginosa isolateAminoglycoside resistance gene ant(4')-IIb of Pseudomonas aeruginosa BM4492, a clinical isolate from Bulgaria.Directed evolution of aminoglycoside phosphotransferase (3') type IIIa variants that inactivate amikacin but impose significant fitness costs.Sequence and characterization of a novel chromosomal aminoglycoside phosphotransferase gene, aph (3')-IIb, in Pseudomonas aeruginosaVersatility of aminoglycosides and prospects for their future.Nucleotide sequence analysis and DNA hybridization studies of the ant(4')-IIa gene from Pseudomonas aeruginosa.Characterization of the aac(6')-Ib gene encoding an aminoglycoside 6'-N-acetyltransferase in Pseudomonas aeruginosa BM2656Increased resistance to amikacin in a neonatal unit following intensive amikacin usage.Characterization of Acinetobacter haemolyticus aac(6')-Ig gene encoding an aminoglycoside 6'-N-acetyltransferase which modifies amikacin.Aminoglycoside resistance in Pseudomonas aeruginosa.Nosocomial spread of an amikacin resistance gene on both a mobilized, nonconjugative plasmid and a conjugative plasmid.Domain dissection and characterization of the aminoglycoside resistance enzyme ANT(3″)-Ii/AAC(6')-IId from Serratia marcescens.Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes.Pharmacokinetics and metabolism of 14C-isepamicin in humans following intravenous administrationPharmacokinetics of intravenously administered isepamicin in men.Pharmacokinetics of isepamicin following a single administration by intravenous infusion or intramuscular injections.Sequences of MGH-1, YOU-1, and YOU-2 extended-spectrum beta-lactamase genes.In vitro antimicrobial susceptibility to isepamicin of 6,296 Enterobacteriaceae clinical isolates collected at a tertiary care university hospital in Greece.Single-dose pharmacokinetics of isepamicin in young and geriatric volunteers.
P2860
Q30995418-9AF0F8F6-4700-4174-89EF-E38796193E0AQ34354185-27EEE51E-50F8-4638-BAEB-EE2D3039AEC0Q34597573-8D72C112-DF6C-4DED-ACED-909E1041E5C4Q34721661-3CEE00B0-C5CC-4FF3-B158-2713B512A949Q34941900-7DDA8B28-6FA3-4B25-8F71-207B5EACAC5FQ35034759-4F89EF6E-BACB-4C89-8061-5E63E50D8CB4Q35124489-8893351B-B912-48CD-84B9-B98C965B94A8Q35176271-95222888-8256-4DC9-84FE-2146A94CBD47Q35811129-88E53C37-D9CE-4891-947F-3906EC3C89ECQ35816982-7963C8A2-04CB-4D7C-B426-65AF5051E9B2Q35893360-0DDA74E9-267F-4D69-B7A3-820675AE7659Q35897284-C0DE6695-BFC3-4043-98D2-707B4DA91BC0Q36021296-76E9F077-71E9-4281-BF40-7E97CA718D51Q36754526-3B07C203-6931-4867-9366-301EB78E8B1CQ36823942-282E6E5F-AFF2-46F0-9055-B473B244A681Q37058913-448470AB-D8E2-46E7-9BA1-9F23D6615D4DQ39780570-5CE6A855-6E4C-4667-B7DF-156E24AAB2C9Q39781051-6D0C3B07-3A28-4BEC-BAC1-E976F4BE08E4Q39784762-68E47F08-5D2F-4610-B79E-EB2E16E701C9Q39883863-C1D0A4BB-5388-4055-A208-7BCD5CDF2844Q41972475-5BC4A7B4-F9E4-4CE4-99D8-B9B88BCACC81Q50902133-31F7DD5A-D301-4FE3-B195-6D1AEF5A018D
P2860
Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens.
description
1990 nî lūn-bûn
@nan
1990 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Appearance of amikacin and tob ...... I] in gram-negative pathogens.
@ast
Appearance of amikacin and tob ...... I] in gram-negative pathogens.
@en
type
label
Appearance of amikacin and tob ...... I] in gram-negative pathogens.
@ast
Appearance of amikacin and tob ...... I] in gram-negative pathogens.
@en
prefLabel
Appearance of amikacin and tob ...... I] in gram-negative pathogens.
@ast
Appearance of amikacin and tob ...... I] in gram-negative pathogens.
@en
P2093
P2860
P356
P1476
Appearance of amikacin and tob ...... I] in gram-negative pathogens.
@en
P2093
P2860
P304
P356
10.1128/AAC.34.12.2381
P407
P577
1990-12-01T00:00:00Z